
BIG Pharma
The United States is witnessing a significant surge in prescription drug prices, impacting consumers nationwide. This trend is influenced by recent price hikes from pharmaceutical companies and policy changes affecting drug coverage and costs.
In early 2025, pharmaceutical companies raised the list prices of over 250 branded medications. Notable examples include Pfizer’s COVID-19 treatment, Paxlovid, and cancer therapies from Bristol Myers Squibb. While most increases remained below 10%, with a median rise of 4.5%, these adjustments contribute to the escalating financial burden on patients. Continue reading